The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations

Soysal, Teoman; Eskazan, Ahmet Emre; Serin, Istemi; Sadri, Sevil; Keskin, Dilek; Yurttas, Nurgul Ozgur; Berk, Selin; Ozunal, Isil Erdogan; Salihoglu, Ayse; Ar, Muhlis Cem; Ongoren, Seniz; Baslar, Zafer; Ozbek, Ugur; Aydin, Yildiz

doi:10.1016/j.clml.2019.03.028

The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations

Date

2019

Authors

Yurttas, Nurgul Ozgur

dc.identifier.doi

10.1016/j.clml.2019.03.028

dc.identifier.other

WOS:000477732800009

Publisher

CIG MEDIA GROUP, LP

DOI

10.1016/j.clml.2019.03.028

Keywords

Chronic myeloid leukemia , European LeukemiaNet \\(ELN\\) , Imatinib , Tyrosine kinase inhibitor , Warning

URI

https://openaccess.acibadem.edu.tr/handle/11443/7984

Collections

WOS

Full item page

The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations

Date

Authors

Journal Title

Journal ISSN

Volume Title

dc.identifier.issn

dc.identifier.doi

dc.identifier.other

dc.description.volume

dc.description.issue

Publisher

DOI

Abstract

Description

Keywords

Citation

URI

Collections

Endorsement

Review

Supplemented By

Referenced By